Blues Health Insurers Back Venture to Lower Generic Drug Prices

A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that aims to offer cheaper prices to their members on generic drugs that currently have little or no competition, the companies said on Thursday. The Blue Cross Blue Shield Association (BCBSA) and 18 Blue Cross Blue Shield health insurers are